| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.06 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.07 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.092 | 0.07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |